Skip to main content

Day: October 23, 2024

FFW Corporation Announces Earnings For The Quarter Ended September 30, 2024

WABASH, Ind., Oct. 23, 2024 (GLOBE NEWSWIRE) — FFW Corporation (the “Corporation”) (OTC PINK: FFWC) (10/22/2024 Close: $39.50), parent corporation of Crossroads Bank (the “Bank”), announced earnings for the quarter ended September 30, 2024. For the three months ended September 30, 2024, the Corporation reported net income of $1,243,000 or $1.09 per common share compared to $978,000 or $0.87 per common share for the three months ended September 30, 2023. Net interest income for the three months ended September 30, 2024 was $3,782,000 compared to $3,645,000 for the three months ended September 30, 2023. The provision for credit losses was $0 for the three months ended September 30, 2024 and September 30, 2023. Total noninterest income was $1,280,000 for the three months ended September 30, 2024 compared to $928,000 for the three...

Continue reading

Bureau Veritas Acquires Aligned Incentives, an Enterprise Sustainability Planning Pioneer, Expanding its Global Sustainability Services with AI Powered Solutions

PRESS RELEASE Paris – October 23, 2024 Bureau Veritas Acquires Aligned Incentives, an Enterprise Sustainability Planning Pioneer, Expanding its Global Sustainability Services with AI Powered Solutions Bureau Veritas, a global leader in testing, inspection, and certification services, today announced the acquisition of Aligned Incentives, an innovative provider of AI-powered sustainability planning solutions. This strategic move enhances Bureau Veritas’ capabilities in Scope 3 emissions analysis and life cycle assessment (LCA). Aligned Incentives is recognized for its top tier AI technology and deep expertise in sustainability metrics, positioning it at the forefront of the rapidly evolving field of sustainability impact assessment. This acquisition represents a pivotal step in Bureau Veritas’ LEAP | 28 strategy, establishing...

Continue reading

Michelin: Group sales reflected OE markets downcycle across segments and contextual headwinds in Specialties, with continued mix improvement.

Clermont-Ferrand – October 23, 2024 – 5:45 pm COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELINFinancial information for the nine months ended September 30, 2024 Group sales reflected OE markets downcycle across segments and contextual headwinds in Specialties, with continued mix improvement. Tire sell-in markets rose over the period, inflated by high imports of Asian tires into Replacement markets. OE markets in sharp downward cycle and deteriorating further in Q3.PC/LT tire demand supported by Replacement markets in Europe and North America. Dealer inventory levels close to normal, with ongoing replenishment of Winter tires in Europe. OE demand deteriorated gradually, with Q3 down 9% in Europe and 5% in North America. Truck tire markets outside China reflected moderate economic growth, with North America inflated by massive imports of...

Continue reading

BIC: THIRD QUARTER & NINE MONTHS 2024 RESULTS

                            Clichy, France – October 23, 2024 THIRD QUARTER & NINE MONTHS 2024 RESULTS Sequential improvement in Q3 Net Sales growthRobust adjusted EBIT margin, 2024 Margin Outlook upgraded Q3 2024 Net Sales of €540 million, up 0.2% at constant currency excl. Argentina1 driven by solid performance in Blade Excellence and return to growth in Flame for Life, partially offset by Human ExpressionHuman Expression: Q3 Net Sales of €200 million, down 4.3%1, impacted by a soft performance in most key regions, except in Middle East and Africa Flame for Life: Q3 Net Sales of €192 million, up 0.7%1, with continued strong growth in Europe and sequential improvement in North America Blade Excellence: Q3 Net Sales of €142 million, up 6.4%1, fueled by solid performance in North America, Europe and Latin AmericaStrong Q3 2024...

Continue reading

Oriental Rise Holding Limited Announces Full Exercise of Underwriter’s Over-Allotment Option

Ningde, China, Oct. 23, 2024 (GLOBE NEWSWIRE) — Oriental Rise Holding Limited (“Oriental Rise” or the “Company”) (NasdaqCM: ORIS), an integrated supplier of tea products in mainland China, today announced US Tiger Securities, Inc. (“US Tiger”), who acted as the underwriter and sole book-runner of the Company’s underwritten initial public offering (“IPO”), has exercised the full over-allotment option and purchased an additional 262,500 ordinary shares of the Company at the IPO price of $4.00 per share. As a result, the Company has raised $8.05 million in gross proceeds, before underwriting discounts and other related expenses, through the issuance of a total of 2,012,500 ordinary shares in the IPO. US Tiger acted as sole book runner for the Offering. The Crone Law Group served as counsel to the Company....

Continue reading

Innovative Food Holdings, Inc. Announces Fulfillment of Largest Purchase Order in the Company’s History

BONITA SPRINGS, Fla., Oct. 23, 2024 (GLOBE NEWSWIRE) — Innovative Food Holdings, Inc. (OTCQB: IVFH) (“IVFH” or the “Company”), a national seller of gourmet specialty foods to professional chefs, announced today the shipment of its largest purchase order in company history through its newly established partnership with a top 10 U.S. retailer. This milestone order totaled $676,000 of gourmet cheese. This order represented an acceleration of approximately twenty times compared to our cheese production rates of only two weeks prior. The scale and complexity of this order highlight the strength of IVFH’s operational capabilities and its commitment to delivering premium products at scale. To meet the demands of this partnership, IVFH recently installed four new high-efficiency packaging machines. This marks a significant expansion...

Continue reading

Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

Aspira aims to develop a multi-marker miRNA blood test to aid in the detection of endometriosis AUSTIN, Texas, Oct. 23, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an awardee of the Sprint for Women’s Health to address critical unmet challenges in women’s health, champion transformative innovations, and tackle health conditions that uniquely or disproportionately affect women. Aspira will receive $10 million in funding over two years through the Sprint for Women’s Health launchpad track for later-stage health solutions. Funding from the project will support the continued development of...

Continue reading

MiddleGround Capital secures 83.54 percent of all shares in Takeover Offer for STEMMER IMAGING AG

THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION WHERE SUCH OFFER PURSUANT TO LEGISLATION AND REGULATIONS IN SUCH RELEVANT JURISDICTION WOULD BE PROHIBITED BY APPLICABLE LAW. LEXINGTON, Ky., Oct. 23, 2024 (GLOBE NEWSWIRE) — Ventrifossa BidCo AG (the “Bidder”), a holding company controlled by MiddleGround Capital (“MiddleGround“) has secured 10.00 percent of all shares of STEMMER IMAGING AG (“STEMMER”; ISIN DE000A2G9MZ9 / GSIN A2G9MZ) in its voluntary public takeover offer for STEMMER (“Takeover Offer”). The additional acceptance period ended on October 18, 2024. In addition, the Bidder has signed a purchase agreement for approximately 69.36 percent of the...

Continue reading

BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference

October 23, 2024 News Release BioPorto Presenting FDA-cleared ProNephro AKI (NGAL) at ASN Kidney Week 2024 Conference COPENHAGEN, Denmark and BOSTON, MA, USA, October 23, 2024, (GLOBE NEWSWIRE) — BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), announced today that they will participate in the upcoming American Society of Nephrology (ASN) Kidney Week 2024. The Kidney Week 2024 Annual Meeting will take place October 24-27, 2024, in San Diego, CA, USA. Kidney Week 2024 is the first ASN Conference after BioPorto received US Food and Drug Administration (FDA) clearance for the ProNephro AKI™ (NGAL) test for risk stratification of Acute Kidney Injury (AKI) in patients 3 months through 21 years of age. Jennifer Zonderman,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.